If FXR improves hepatic steatosis as well as heals the injury in fatty liver or NASH, the signals of FXR-p62/SQSTM1 may play a pivotal role in maintaining liver homeostasis and protection against injury especially of fatty liver. This evidence concerns the gene SQSTM1 and metabolic dysfunction-associated steatohepatitis.